EMA SPOR Working group release the details to the SPOR Change Liaison Group
EMA SPOR Working group release the details to the SPOR ...
Technology Considerations to Enable Communication and Collaboration in Medical Affairs Information Management
Our first blog on this topic addressed “The importance of mobility and medical affairs (MA) and its value to the organization is most definitely on the rise.” In this concluding blog we share specific examples of how mobile technology improves MA and arms you with the criteria and questions to ask as you investigate possible medical information solutions.
Signal Detection & eRMR: New EudraVigilance System Is Almost Here – Are You Ready?
For many companies, signal detection in drug safety pharmacovigilance ranks closely behind regulatory submissions and case management as a key activity because it helps to proactively monitor a product’s risks that come to light from tracking the data submitted to internal and external drug safety databases and platforms.
Mobility and Medical Affairs: Enabling Communication and Collaboration across the Stakeholder Spectrum – Part 1
“The most competitive pharma companies in the coming decade will be masters of data and digital technologies.” So begins the June 2017 industry brief, “Reinventing the Role of Medical Affairs,” by Bain & Company.
Newscast: LifeSphere® Mobile MA – Self Service Medical Information Portal for Medical Affairs and Pharmacovigilance
LifeSphere® Mobile MA is the first multi-lingual, self-service medical information ...
Newscast: ArisGlobal Launches LifeSphere® Clinical
LifeSphere® Clinical is the industry’s first pre-validated, unified eClinical research ...
Removing the Squeeze on Clinical Operations through Transparency, Integration and Automation
From reporting challenges to data integration and data silos with ...
ArisGlobal Newscast: Industry’s Only E2B R3 Compliant Safety Multi-Tenant Cloud Platform
LifeSphere® Safety MultiVigilance is the only E2B R3 compliant multi-tenant ...
Connected to the Future: Making Drug Safety Databases Transparent, E2B R3 Compliant and Cost-Effective
As different regulatory authorities have different timelines for adoption of these standards, E2B(R2) E2B(R3) will have to coexist. But having to operate two solutions creates huge complexities, unless you find a solution compliant with both. ArisGlobal LifeSphere Safety MultiVigilance is the only drug safety database solution provider thus far to provide full compliance to E2B R2 and E2B R3 standards for both import and export.
Blog: Automation in ICSR Processing – Is Artificial Intelligence the Paradigm Shift in Pharmacovigilance?
Artificial intelligence (AI), machine learning, deep learning, natural language processing ...
